Long-Term Gonadotropin-Releasing Hormone Agonist With Standard Postmenopausal Estrogen Replacement Failed to Prevent Vertebral Bone Loss in Premenopausal Women

Estrogen Replacement ◽

Vertebral Bone ◽

Releasing Hormone ◽

Postmenopausal Estrogen

Long-term gonadotropin-releasing hormone agonist with standard postmenopausal estrogen replacement failed to prevent vertebral bone loss in premenopausal women

Fertility and Sterility ◽

10.1016/s0015-0282(16)56220-7 ◽

1993 ◽

Vol 60 (4) ◽

pp. 672-674 ◽

Cited By ~ 18

Author(s):

Akira K. Sugimoto ◽

Anthony B. Hodsman ◽

Jeffrey A. Nisker

Keyword(s):

Bone Loss ◽

Premenopausal Women ◽

Estrogen Replacement ◽

Vertebral Bone ◽

Releasing Hormone ◽

Postmenopausal Estrogen

Efficacy of a gonadotropin-releasing hormone agonist in the treatment of uterine leiomyomata: long-term follow-up**The opinions expressed herein represent those of the authors and not those of the Department of the Army, Department of the Navy, or Department of Defense.

Fertility and Sterility ◽

10.1016/s0015-0282(16)60724-0 ◽

1989 ◽

Vol 51 (6) ◽

pp. 951-956 ◽

Cited By ~ 50

Author(s):

Gerard S. Letterie ◽

Charles C. Coddington ◽

Craig A. Winkel ◽

Thomas H. Shawker ◽

D. Lynn Loriaux ◽

...

Keyword(s):

Department Of Defense ◽

Uterine Leiomyomata ◽

Releasing Hormone ◽

Long Term Follow Up ◽

Department Of The Navy ◽

Department Of The Army

For premenopausal women with cancer, what are the effects of adding a gonadotropin-releasing hormone agonist to chemotherapy?

Cochrane Clinical Answers ◽

10.1002/cca.2534 ◽

2019 ◽

Author(s):

Jane Burch ◽

Mohammed R Houda

Keyword(s):

Premenopausal Women ◽

Releasing Hormone ◽

Long-Term Effects of Gonadotropin-Releasing Hormone Agonist and Add-Back in Adolescent Endometriosis

Journal of Pediatric and Adolescent Gynecology ◽

10.1016/j.jpag.2018.02.074 ◽

2018 ◽

Vol 31 (2) ◽

pp. 190

Author(s):

Jenny Sadler Gallagher ◽

Stacey A. Missmer ◽

Mark D. Hornstein ◽

Marc R. Laufer ◽

Catherine M. Gordon ◽

...

Keyword(s):

Long Term Effects ◽

Releasing Hormone ◽

Faculty Opinions recommendation of Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1090563.543843 ◽

2007 ◽

Author(s):

Frederick Singer

Keyword(s):

Prostate Cancer ◽

Randomized Controlled Trial ◽

Zoledronic Acid ◽

Bone Loss ◽

Controlled Trial ◽

Releasing Hormone ◽

Randomized Controlled

Erratum to: Raloxifene Administration in Women Treated with Long Term Gonadotropin-releasing Hormone Agonist for Severe Endometriosis: Effects on Bone Mineral Density

Journal of Menopausal Medicine ◽

10.6118/jmm.2017.23.1.77 ◽

2017 ◽

Vol 23 (1) ◽

pp. 77

Author(s):

Young Hwa Cho ◽

Mi Jung Um ◽

Suk Jin Kim ◽

Soo Ah Kim ◽

Hyuk Jung

Keyword(s):

Bone Mineral Density ◽

Bone Mineral ◽

Mineral Density ◽

Releasing Hormone ◽

Authors’ Response: Spironolactone But Not Flutamide Administration Prevents Bone Loss in Hyperandrogenic Women Treated with Gonadotropin-Releasing Hormone Agonist

The Journal of Clinical Endocrinology & Metabolism ◽

10.1210/jcem.84.12.4747b ◽

1999 ◽

Vol 84 (12) ◽

pp. 4747-b-4747

Author(s):

Paolo Moghetti ◽

Roberto Castello ◽

Nicoletta Zamberlan ◽

Maurizio Rossini ◽

Davide Gatti ◽

...

Keyword(s):

Bone Loss ◽

Releasing Hormone ◽

Single or repeated gonadotropin-releasing hormone agonist treatment avoids hysterectomy in premenopausal women with large symptomatic fibroids with no effects on sexual function

Journal of Obstetrics and Gynaecology Research ◽

10.1111/jog.12135 ◽

2013 ◽

Vol 40 (1) ◽

pp. 117-124 ◽

Cited By ~ 4

Author(s):

Anna Myriam Perrone ◽

Federica Pozzati ◽

Barbara Di Marcoberardino ◽

Martina Rossi ◽

Martina Procaccini ◽

...

Keyword(s):

Sexual Function ◽

Premenopausal Women ◽

Releasing Hormone ◽

Hormonal Pattern and Testicular Histology in Patients with Prostatic Cancer after Long-Term Treatment with a Gonadotropin-Releasing Hormone Agonist Analogue

European Urology ◽

10.1159/000473411 ◽

1988 ◽

Vol 15 (1-2) ◽

pp. 125-127 ◽

Cited By ~ 12

Author(s):

Claudio Giberti ◽

Tommaso Barreca ◽

Giuseppe Martorana ◽

Mauro Truini ◽

Roberto Francheschini ◽

...

Keyword(s):

Prostatic Cancer ◽

Term Treatment ◽

Releasing Hormone ◽

Long Term Treatment ◽

Testicular Histology

Comparison of long-term use of combined oral contraceptive after gonadotropin-releasing hormone agonist plus add-back therapy versus dienogest to prevent recurrence of ovarian endometrioma after surgery

European Journal of Obstetrics & Gynecology and Reproductive Biology ◽

10.1016/j.ejogrb.2019.02.032 ◽

2019 ◽

Vol 236 ◽

pp. 53-57

Author(s):

Jong-Wook Seo ◽

Dong-Yun Lee ◽

Sung Eun Kim ◽

Byung-Koo Yoon ◽

DooSeok Choi

Keyword(s):

Oral Contraceptive ◽

Releasing Hormone ◽

Combined Oral Contraceptive ◽

Ovarian Endometrioma